Stocks
Funds
Screener
Sectors
Watchlists
HQY

HQY - HealthEquity Inc Stock Price, Fair Value and News

$82.86-0.16 (-0.19%)
Market Closed

54/100

HQY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

54/100

HQY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$81.33

Target 3M

$83.44

Target 6M

$82.68

HQY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HQY Price Action

Last 7 days

-2.1%

Last 30 days

-10.7%

Last 90 days

-10.9%

Trailing 12 Months

-23.1%

HQY RSI Chart

HQY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HQY Valuation

Market Cap

7.1B

Price/Earnings (Trailing)

36.9

Price/Sales (Trailing)

5.48

EV/EBITDA

18.41

Price/Free Cashflow

17.14

HQY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$81.33

Target 3M

$83.44

Target 6M

$82.68

HQY Fundamentals

HQY Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

7.23%

Rev. Growth (Qtr)

-1.13%

HQY Earnings

Earnings (TTM)

191.8M

Earnings Growth (Yr)

806.4%

Earnings Growth (Qtr)

-13.64%

HQY Profitability

EBT Margin

19.10%

Return on Equity

8.99%

Return on Assets

5.65%

Free Cashflow Yield

5.83%

HQY Investor Care

Buy Backs (1Y)

1.42%

Diluted EPS (TTM)

2.18

HQY Alerts

  • 1 major insider sales recently.
  • Big jump in Earnings (Y/Y)

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.2B1.2B1.3B1.3B
2024999.6M1.0B1.1B1.2B
2023861.7M900.5M937.9M971.0M
2022756.6M778.0M795.1M831.2M
2021733.6M727.8M740.8M741.4M
2020532.0M635.0M724.4M746.6M
2019287.2M304.4M319.9M406.6M
2018229.5M244.0M258.2M271.9M
2017178.4M189.8M202.5M215.9M
2016126.8M140.9M154.6M167.4M
201587.9M97.5M107.1M115.8M
201462.0M67.6M73.5M80.1M
201346.1M50.1M54.1M58.0M
HQY
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
 CEO
 WEBSITEhealthequity.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES3170

HealthEquity Inc Frequently Asked Questions


HQY is the stock ticker symbol of HealthEquity Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of HealthEquity Inc is 7.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HQY's fair value in chart for subscribers.

The fair value guage provides a quick view whether HQY is over valued or under valued. Whether HealthEquity Inc is cheap or expensive depends on the assumptions which impact HealthEquity Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HQY.

As of Wed Jan 28 2026, HQY's PE ratio (Price to Earnings) is 36.9 and Price to Sales (PS) ratio is 5.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HQY PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, HealthEquity Inc has provided 0.144 (multiply by 100 for percentage) rate of return.